Fund Holdings — Cutter Capital Management, LP

Total Portfolio Value:
$229.65M
Total Bought:
$127.71M
Total Sold:
$140.96M
Net Transaction:
-$13.26M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)0295,000+295,000$0$17.99M7.83%+$17.99M
Amgen Inc.(AMGN)38,09050,000+11,910$9.93M$15.58M6.78%+$5.65M
Biogen Inc.(BIIB)0113,500+113,500$0$15.53M6.76%+$15.53M
Eli Lilly and Company(LLY)018,000+18,000$0$14.87M6.47%+$14.87M
Insmed Incorporated(INSM)210,884186,384-24,500$14.56M$14.22M6.19%-$340.2K
Ultragenyx Pharmaceutical Inc.(RARE)406,803379,303-27,500$17.11M$13.73M5.98%-$3.38M
BridgeBio Pharma, Inc.(BBIO)560,344390,644-169,700$15.38M$13.50M5.88%-$1.87M
Perrigo Company plcSHS(PRGO)294,517479,517+185,000$7.57M$13.45M5.85%+$5.87M
Roivant Sciences Ltd.SHS(ROIV)01,300,000+1,300,000$0$13.12M5.71%+$13.12M
Teva Pharmaceutical Industries LimitedADS(TEVA)584,883801,806+216,923$12.89M$12.32M5.37%-$567.1K
Royalty Pharma plcCL A(RPRX)764,859356,894-407,965$19.51M$11.11M4.84%-$8.40M
Tarsus Pharmaceuticals, Inc.(TARS)112,500205,000+92,500$6.23M$10.53M4.59%+$4.30M
Verona Pharma PlcADS0160,000+160,000$0$10.16M4.42%+$10.16M
Madrigal Pharmaceuticals, Inc.(MDGL)024,000+24,000$0$7.95M3.46%+$7.95M
Summit Therapeutics Inc.(SMMT)0400,000+400,000$0$7.72M3.36%+$7.72M
Halozyme Therapeutics, Inc.(HALO)0120,000+120,000$0$7.66M3.33%+$7.66M
Cytokinetics, Incorporated(CYTK)0175,000+175,000$0$7.03M3.06%+$7.03M
Agios Pharmaceuticals, Inc.(AGIO)301,623235,350-66,273$9.91M$6.90M3.00%-$3.02M
Centessa Pharmaceuticals PlcADS147,076418,127+271,051$2.46M$6.01M2.62%+$3.55M
Arcus Biosciences, Inc.(RCUS)0731,818+731,818$0$5.74M2.50%+$5.74M
Newamsterdam Pharma Company
ORDINARY SHARES
337,152221,152-116,000$8.66M$4.53M1.97%-$4.14M
AbbVie Inc.(ABBV)101,9960-101,996$18.12M$0—-$18.12M
Akero Therapeutics Inc230,0000-230,000$6.40M$0—-$6.40M
Janux Therapeutics, Inc.(JANX)120,0000-120,000$6.42M$0—-$6.42M
Johnson & Johnson(JNJ)141,5720-141,572$20.47M$0—-$20.47M
Moderna, Inc.(MRNA)197,5000-197,500$8.21M$0—-$8.21M
Neumora Therapeutics, Inc.(NMRA)150,0000-150,000$1.59M$0—-$1.59M
Regeneron Pharmaceuticals, Inc.(REGN)31,5000-31,500$22.44M$0—-$22.44M
Sarepta Therapeutics, Inc.(SRPT)124,2560-124,256$15.11M$0—-$15.11M
Vera Therapeutics, Inc.CL A(VERA)212,6960-212,696$8.99M$0—-$8.99M
Viridian Therapeutics, Inc.(VRDN)628,6770-628,677$12.05M$0—-$12.05M
Page 1 of 1
Cutter Capital Management, LP — 13F Holdings — Q1 2025 | TickerTrail